UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

PloS one, 2020-05, Vol.15 (5), p.e0232394

2020

Volltextzugriff (PDF)

Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems

Endocrine reviews, 2003-12, Vol.24 (6), p.737-764

2003

Volltextzugriff (PDF)

Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides

Nature biotechnology, 2000-05, Vol.18 (5), p.521-526

2000

Volltextzugriff (PDF)

Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3004-3004

2024

Volltextzugriff (PDF)

Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.374-374

2024

Volltextzugriff (PDF)

Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye

Investigative ophthalmology & visual science, 2005-08, Vol.46 (8), p.2708-2715

2005

Volltextzugriff (PDF)

Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3014-3014

2024

Volltextzugriff (PDF)

Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment

Kidney international, 2000-07, Vol.58 (1), p.62-70

2000

Volltextzugriff (PDF)

Calcium Regulates the Expression of Insulin-Like Growth Factor Binding Protein-3 by the Human Keratinocyte Cell Line HaCaT

Journal of investigative dermatology, 2001-04, Vol.116 (4), p.491-497

2001

Volltextzugriff (PDF)

Abstract B039: A phase 1/2 study of dendrimer-enhanced (DEP) SN38 (SN38-SPL9111/DEP irinotecan) in patients with advanced solid tumours

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.B039-B039

2023

Volltextzugriff (PDF)

UV induced responses of the human epidermal IGF system: Impaired anti-apoptotic effects of IGF-I in HaCaT keratinocytes

Growth factors (Chur, Switzerland), 2005-06, Vol.23 (2), p.151-159

2005

Volltextzugriff (PDF)

Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3γ

The Journal of biological chemistry, 1997-11, Vol.272 (45), p.28779-28785

1997

Volltextzugriff (PDF)

Interactions between Growth Hormone, Insulin-Like Growth Factor I, and Basic Fibroblast Growth Factor in Melanocyte Growth1

The journal of clinical endocrinology and metabolism, 1999-05, Vol.84 (5), p.1638-1644

1999

Volltextzugriff (PDF)

Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGF?1

Journal of cellular physiology, 1999-05, Vol.179 (2), p.201-207

1999

Volltextzugriff (PDF)

Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth

The journal of clinical endocrinology and metabolism, 1999-05, Vol.84 (5), p.1638-1644

1999

Volltextzugriff (PDF)

Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye

Investigative ophthalmology & visual science, 1996-06, Vol.37 (7), p.1459-1468

1996

Volltextzugriff (PDF)

Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFβ1

Journal of cellular physiology, 1999-05, Vol.179 (2), p.201-207

1999

Volltextzugriff (PDF)

Uterine dysfunction and genetic modifiers in centromere protein B-deficient mice

Genome research, 2000-01, Vol.10 (1), p.30

2000

Volltextzugriff (PDF)

Expression of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) in the Psoriatic Lesion

Journal of investigative dermatology, 1997-04, Vol.108 (4), p.452-456

1997

Volltextzugriff (PDF)

Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney

Kidney international, 1995-08, Vol.48 (2), p.402-411

1995

Volltextzugriff (PDF)

Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3Î

The Journal of biological chemistry, 1997-11, Vol.272 (45), p.28779

1997

Volltextzugriff (PDF)

Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes

Journal of cellular physiology, 1995-05, Vol.163 (2), p.339-345

1995

Volltextzugriff (PDF)

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Journal of clinical oncology, 2020-10, Vol.38 (29), p.3388-3397

2020

Volltextzugriff (PDF)

Phase separation drives aberrant chromatin looping and cancer development

Nature (London), 2021-07, Vol.595 (7868), p.591-595

2021

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Englisch
(81)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems

Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides

Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2)

Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial

Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye

Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial

Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment

Calcium Regulates the Expression of Insulin-Like Growth Factor Binding Protein-3 by the Human Keratinocyte Cell Line HaCaT

Abstract B039: A phase 1/2 study of dendrimer-enhanced (DEP) SN38 (SN38-SPL9111/DEP irinotecan) in patients with advanced solid tumours

UV induced responses of the human epidermal IGF system: Impaired anti-apoptotic effects of IGF-I in HaCaT keratinocytes

Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3γ

Interactions between Growth Hormone, Insulin-Like Growth Factor I, and Basic Fibroblast Growth Factor in Melanocyte Growth1

Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGF?1

Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth

Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye

Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFβ1

Uterine dysfunction and genetic modifiers in centromere protein B-deficient mice

Expression of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) in the Psoriatic Lesion

Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney

Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3Î

Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Phase separation drives aberrant chromatin looping and cancer development

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Aktive Filter

Suchergebnisse filtern